Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.16967 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Takuya Takeichi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Pityriasis Rubra Pilaris, Ichthyosis, Lamellar, Ichthyosiform Erythroderma, Congenital, Ichthyosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Boehringer Ingelheim, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.
Abstract (Originalsprache)
Pathogenic variants in ABCA12 are important causative genetic defects for autosomal recessive congenital ichthyoses (ARCI), which include congenital ichthyosiform erythroderma (CIE), harlequin ichthyosis, and lamellar ichthyosis. In addition, pathogenic variants in ABCA12 are known to cause a localized nevoid form of CIE due to recessive mosaicism. We previously reported siblings who carried an ABCA12 variant but did not show a “congenital” phenotype. They were considered to have pityriasis rubra pilaris (PRP). Here, we present a further patient with ABCA12 variants whose phenotype was not congenital ichthyosis, in an independent family. Notably, these three patients had geographic unaffected areas. Such areas are not usually found in patients with ARCI who have ABCA12 variants, suggesting mild phenotypes for these patients. Interestingly, the histological features of the ichthyotic lesions in these patients resembled those of PRP. All three patients had homozygous pathogenic missense variants in ABCA12 . Our findings expand the phenotypic spectrum of patients with ABCA12 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
- Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.
- Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.
- Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan.
- Department of Human Genetics and Molecular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Takuya Takeichi, Takahiro Hamada, Yasutoshi Ito, Hiroshi Koga, Norito Ishii, Yoshinao Muro, Masashi Akiyama
Förderung
- Boehringer Ingelheim
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
- Health and Labor Sciences Research Grant for Research on Intractable Diseases
- Ministry of Health, Labor and Welfare of Japan
- JST FOREST Program
- JSPS KAKENHI
Zitieren
APA
Takeichi, T., Hamada, T., Yamamoto, M., Ito, Y., Kawaguchi, A., Kobashi, H., Yoshikawa, T., Koga, H., Ishii, N., Nakama, T., Muro, Y., Ogi, T., & Akiyama, M. (2024). Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16967
Vancouver
Takeichi T, Hamada T, Yamamoto M, Ito Y, Kawaguchi A, Kobashi H, et al. Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.16967
BibTeX
@article{Takeichi2024,
author = {Takeichi, Takuya and Hamada, Takahiro and Yamamoto, Mayuko and Ito, Yasutoshi and Kawaguchi, Aya and Kobashi, Haruka and Yoshikawa, Takenori and Koga, Hiroshi and Ishii, Norito and Nakama, Takekuni and Muro, Yoshinao and Ogi, Tomoo and Akiyama, Masashi},
title = {Patients with keratinization disorders due to ABCA12 variants showing pityriasis rubra pilaris phenotypes},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.16967}
}
EUVIMED